The majority of elderly men are affected by benign and malign diseases of the prostate that are governed by endocrine factors and local stromal/epithelial and luminal/epithelial interactions. Prostate epithelial cells secrete numerous factors into the seminal plasma (SMP) that are thought to be responsible for nutrition, accurate pH, and ionic environment of sperm. Our hypothesis assumes that prostatic factors responsible for optimal fertility might have retrograde influences on epithelial cell growth, differentiation, and function. SMP was analyzed for proteins and other biologically active substances by size exclusion highperformance liquid chromatography. Each fraction was investigated for its effect on cell growth and death. A low molecular mass fraction (2-4 kDa) was responsible for inducing apoptosis in proliferating prostate epithelial cells. Signal transduction was mediated by the production of cAMP; no significant changes in tyrosine phosphorylation of membrane receptors were observed. Mechanisms of apoptosis, i.e., caspase-and mitochondria-dependent pathways, were investigated in prostate epithelial cells by caspase activity assays, annexin/propidium iodide staining, changes in mitochondrial potential, p53, Par-4, Bax, and Bcl-2 protein levels. SMP induced p53-and Bcl-2-dependent apoptosis without activation of caspase-3. Obviously, SMP contains protective factors that help eliminate degenerated cells and control epithelial renewal. Age-related changes in the composition of SMP or the susceptibility of epithelial cells might, therefore, contribute to proliferative prostatic diseases.-Untergasser, G., Rumpold, H., Plas, E., Madersbacher, S., Berger, P. A low molecular weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3-independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl-2/Bax ratio. FASEB J. 15, 673-683 (2001) 
Aberrations in growth of the human prostate gland produce some of the most common, costly, and devastating diseases in the aging male. Overgrowth of the prostate resulting in benign prostatic hyperplasia (BPH) has been detected in almost 80% of the male population by the age of 80, and 25% require surgery at some time to alleviate urinary obstruction (1) . Furthermore, clinical prostatic cancer (PCa) develops in 1 in every 11 white males and 1 in every 10 black males in the U.S. during their lifetimes, representing the most common cancer in the male after lung cancer (2) .
Although the etiology of prostatic proliferative disorders is unknown, development and function of the prostate are thought to be mainly under endocrine control. Epithelial development is stimulated and secretory function is maintained by continuing presence of serum testosterone, which must be converted by the prostatic 5-␣ reductase into dihydrotestosterone. Recently, it has been shown that pituitary-derived prolactin (hPRL) and growth hormone influence prostatic growth and function (3) (4) (5) (6) . In addition, auto/paracrine factors deriving from stromal and/or epithelial cells are important regulators of prostatic growth (7) . Fibroblast growth factors, epidermal growth factor (EGF), transforming growth factors ␣ and ␤ (TGF-␣, TGF-␤), and insulin-like growth factors and their corresponding binding proteins (IGFs, IGFBPs) provide homeostasis of cell replication and cell death, which seems to be disturbed in elderly men.
Prostatic epithelial cells secrete numerous proteins and other substances into the seminal plasma (SMP). We postulate that such luminal factors, originally needed for optimal fertility, act on prostate epithelial cells by influencing growth, differentiation, and secretory function. Moreover, luminal factors beneficial for reproduction in young men could promote aberrant prostatic cell growth in the elderly.
SMP predominantly contains secretions from sex accessory tissue, with the major contributions from seminal vesicle and prostate. In relation to other body fluids, SMP is unique because of its very high concentrations of zinc (150 g/ml), citric acid (4 mg/ml), fructose (2 mg/ml), spermine (3 mg/ml), prostaglandins (200 g/ml), and proteins (40 mg/ml) (8) . SMP contains powerful immunosuppressive agents considered to prolong the life of spermatozoa and to prevent hypersensitization of the female to proteins present on the surface of sperms (9) . SMP from normal fertile men revealed a pattern of over 200 proteins ranging in molecular mass from 10 to 100 kDa (10) . Most proteins originate from the prostate (8) , like prostate-specific antigen prostatic acid phosphatase, prostate-specific protein (PSP-94), and Zn-␣ 2 glycoprotein. Furthermore, neuroendocrine peptides (somatostatin and serotonin) and thyrotropin-releasing hormone-like peptides have been described in SMP (11) .
The aim of this study was to isolate and analyze factors from human SMP regulating prostate epithelial cell proliferation, viability, and differentiation. SMP was fractionated by size exclusion high-performance liquid chromatography (HPLC) and single fractions analyzed for growth stimulatory, inhibitory, and apoptotic effects. Furthermore, SMP-derived substances inducing apoptosis in prostate epithelial cells were compared in their actions and cell death pathways to the classic apoptotic stimulus, UV irradiation.
MATERIALS AND METHODS

Seminal fluid and cell lines
Human seminal fluid was obtained from healthy donors (nϭ12, age: 28 -40). After liquefaction (ϳ 1 h), spermatozoa were removed by centrifugation (1000 g, 20 min, 4°C) and the supernatants were stored at Ϫ20°C for up to 8 wks. Samples were diluted 1:2 with RPMI 1640 (BioWhittaker, Verviers, Belgium) containing 10 mg/ml penicillin, 100 units/ml streptomycin, and 10 mg/ml L-glutamine (PSG) and pooled.
BPH-1 cells were obtained from the German Collection of Microorganisms and Tissue Cultures (DSMZ, Braunschweig, Germany). This cell line has been derived from the epithelium of prostatic tissue obtained from a 65-year-old Caucasian patient suffering from benign prostatic hyperplasia. The primary culture was immortalized with the SV-40 large T antigen, and one isolated clone was designated BPH-1 (12) .
Both androgen-independent PC 3, derived from a primary prostatic tumor, and androgen-dependent LnCAP, isolated from prostate cancer metastasis, were obtained from the American Tissue Type Culture Collection (Rockville, Md.). All cell lines were cultured in RPMI 1640 containing 5% bovine calf serum (BCS, A-2151-L, Hyclone, Logan, Utah) and PSG. Human prostate epithelial cells were obtained from a patient (68 years) suffering from hormonally untreated prostatic cancer. After radical prostatectomy a cube of ϳ0.125 cm 3 was removed from an area containing no histological signs of tumor. After mechanical disruption, small organoids (1-5 mm 3 ) were cultured on Biocoat® collagen type I-coated discs (Becton Dickinson, Vienna, Austria). Organoids were cultured in RPMI 1640 containing PSG and 10% BCS for a least 7 days. Most organoids attached and were surrounded by outgrown cells of epithelial origin, which stained positive for the marker cytokeratin 8/18 (Autogen Bioclear, Wiltshire, U.K.). 
HPLC analysis of SMP
Proliferation/cell viability assays
Cells were seeded at a density of 5000 cells/well into a 96-well microtiter plate and, after adherence (5 h), were incubated with SMP (0.1-3.2%) in the presence of serum or under serum-free conditions. The effects of prostaglandins (PGE-1, PGE-2), dihydrotestosterone, and ␤-estradiol (Sigma Chemical, St. Louis, Mo.) were analyzed at concentrations ranging from 10 Ϫ5 to 10
Ϫ8
. Cell viability, i.e., activity of mitochondrial succinate dehydrogenase, was determined by cleavage of the tetrazolium salt WST-1 to formazan (Boehringer Mannheim, Mannheim, Germany) after 24 and 48 h. Each well was incubated with a 1:10 dilution of WST-1 for 30 min and the optical density (OD) was determined at 450 nm in a multiwell spectrophotometer (ELISA reader, Dynatech MR 5000).
DNA synthesis (proliferation) was determined by a slightly modified 5-Bromo-2Јdeoxy-uridine (BrdU) labeling and detection kit (Boehringer Mannheim). In brief, cells were incubated for 2 h with 10 M BrdU, fixed, and permeabilized at Ϫ20°C for 20 min with a chilled buffer consisting of 70% ethanol and 50 mM glycine (pH 2). Thereafter, they were incubated with 0.5 g/ml antibody directed against BrdU for 1 h. Detection was performed by the use of biotinylated anti-mouse immunoglobulin, streptavidin HRP conjugate (Dako, Denmark), and a peroxidase substrate set consisting of Sigma Fast™ 3,3-diaminobenzidine tetrahydrochloride with metal enhancer tablets (Sigma).
Annexin V/propidium iodide (PI) staining and fluorescence-activated cell sorting (FACS) analysis
Log-phase growing BPH-1 cells (1ϫ10 6 ) seeded into 6-well plates (ϳ40% confluence) were incubated with 2% SMP under growth stimulation with 1% BCS. In parallel, control cells were irradiated with UV light (1 kJ/m 2 ). Cells were harvested after 2, 4, 6, and 10 h by centrifugation (300 g, 5 min, 4°C), washed with ice-cold PBS, and resuspended in 1 ml binding buffer (10 mM HEPES/NaOH pH 7.4, 1.4 mM NaCl, 2.5 mM CaCl 2 ). One hundred microliters of each cell suspension was incubated with 5 l annexin V-FITC (PharMingen, San Diego, Calif.) and 10 l PI (50 g/ml) for 15 min in the dark. Then cells were analyzed by flow cytometry (FACScan, Becton Dickinson) and data were processed by the use of the Cell Quest software (Becton Dickinson).
For cellular DNA fragmentation analyses, UV-irradiated (1 kJ/m 2 ) and SMP-incubated (2%) cells were fixed and permeabilized with ice-cold 70% EtOH, washed in PBS, stained with propidium iodide solution (10 g/ml, 10 min), and subsequently analyzed by flow cytometry.
Fluorescence staining of nucleus and cytoskeleton
Log-phase growing cells were cultivated in glass chamber slides (Labtech® Nalco, Nunc International, Naperville, Ill.) and thereafter exposed to 1% SMP. For staining of cytoskeleton and nuclei, cells were fixed with 4% paraformaldehyde/ PBS for 20 min and permeabilized for 10 min with 0.2% Triton X-100 in PBS. Chamber slides were rinsed with PBS (10 min) and incubated with 100 ng/ml TRITC-labeled phalloidin dissolved in PBS (visualizing filamentous actin, Sigma), 1 ng/ml Sytox green (Molecular Probes, Eugene, Oreg.), or 100 ng/ml 4Ј 2-diamine-2Ј-phenylindole dihydrochloride (DAPI, Boehringer Mannheim), respectively. Cells were washed twice with PBS for 5 min and either viewed on a fluorescent microscope (Leitz) and photographed with Kodak Ektachrome 160T or investigated by the -Radiance confocal scanning (Bio-Rad, Hercules, Calif.). Mitochondria were stained with the JC-1 mitochondrial potential sensor (Molecular Probes). Log-phase growing BPH-1 cells were cultivated in glass chamber slides and exposed to 1% SMP for 2, 4, and 6 h. After extensive washing in culture medium, cells were incubated with 1 g/ml JC-1 (5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethyl-benzimidazolylcarbocyanine-iodide, Molecular Probes) for 30 min, washed twice (PBS), embedded in culture medium, and immediately viewed on the confocal scanning system.
Western blots
Log-phase growing BPH-1 cells (4ϫ10 6 ) were seeded into a plate; after adherence, culture medium was changed to RPMI 1640 containing 1% BCS. Cells were either incubated with 1% SMP or UV irradiated (1 kJ/m 2 ). Whole cell extracts were prepared after 3, 6, and 9 h of incubation (37°C) by lysing each sample in 0.5 ml buffer consisting of 10 mM Tris-HCl (pH 7.5), 125 mM NaCl, 1% Triton X-100, 1 mM PMSF, and a protease inhibitor mixture (Complete™ protease inhibitor mixture, Boehringer Mannheim). Cell extracts were incubated on ice for 20 min and centrifuged (13,000 g, 4°C, 20 min). The protein concentration of the supernatant was determined in a Bradford protein assay (13) .
One hundred micrograms protein of each whole cell extract was boiled for 10 min in denaturating sample buffer consisting of 10% glycerol, 1% SDS, 1% ␤-mercaptoethanol, 10 mM Tris-HCl (pH 6.8), and 0.01% bromphenol blue, then separated on 4 -20% acrylamide gel and transferred on an Immuno-Blot™ PVDF Membrane (Bio-Rad). After blocking in 3% skim milk powder dissolved in PBS, the membrane was incubated for 90 min with 0.1 g/ml PCNA, 0.1 g/ml p53, 1 g/ml Par-4, 2 g/ml cytochrome c, 2 g/ml Bax (Santa Cruz Biotechnology, Santa Cruz, Calif.), and 2 g/ml Bcl-2 antibodies (Oncogene, Cambridge, Mass.). Subsequently, the blot was washed three times in 0.05% Tween 20 in PBS and incubated with 1:5,000 dilutions of goat anti-mouse or goat anti-rabbit conjugates (IgG-HRP, Pierce, Rockford, Ill.), respectively. After extensive washing in 0.05% Tween 20/PBS, a chemoluminescent substrate (SuperSignal®, Pierce), mixed with equal volumes of enhancer and luminol was added to the membrane, which was incubated for 5 min and exposed to the ECL™ Hyperfilm™ (Amersham, Buckinghamshire, U.K.).
Caspase 3 activity
Caspase 3 activity was determined by cleavage of by the biological substrate poly-(ADP-ribose) polymerase (PARP) from 116 kDa into a 89 kDa fragment. Log-phase growing BPH-1 cells (5ϫ10 6 ) were either exposed to 1% SMP or UV irradiated (1 kJ/m 2 ). Nuclear extracts were prepared after 6, 9, 12, 15, 18 and 21 h. Cells were trypsinized, washed, and the cell pellet was resuspended in 135 l lysis buffer consisting of 100 mM Tris-HCl pH 7.3, 500 mM NaCl, 12 mM 2-mercaptoethanol, 25 mM K 2 S 2 O 5 , and 17% glycerin. After three freeze/thaw cycles, 45 l protamine sulfate (1%) was added and the extracts were centrifuged for 30 min (10,000 g, 4°C). Nuclear extracts were desalted by spinning through a Sephadex G25 column (5 min, 500 g). Denaturating sample buffer was added to the desalted probes, which were separated on 10% acrylamide gels. Western blot was performed as described earlier except that an anti-PARP polyclonal rabbit IgG (0.5 g/ml, Upstate Biotechnology, Lake Placid, N.Y.) was used.
To determine caspase activity, a caspase 3 colorimetric protease assay was performed. Log-phase growing BPH-1 cells (1ϫ10 7 ) were lysed after 3, 6, and 9 h of incubation with 1% SMP in 200 l buffer consisting of 50 mM HEPES/NaOH pH 7.4, 100 mM NaCl, 1% glycerol, 0.1% CHAPS (Sigma), 10 mM DTT, 0.1 mM EDTA. After sonification on ice, solubilized cells were centrifuged (15 min, 4°C, 10,000 g) and 90 l cytosolic extract/well was incubated with 10 l colorimetric caspase 3 substrate Ac-DEVD-pNA (Alexis Biochemicals, Läufelingen, Switzerland). After 1 h of incubation at 37°C, the OD of the 96-well microtiter plate was determined at 410 nm in the multiwell spectrophotometer.
cAMP [ 125 I] assay system
BPH-1 cells (1ϫ10 6 ) were starved for 24 h in serum-free medium, then stimulated for 3 h with single HPLC fractions diluted 1:10 in RPMI 1640 (containing 1ϫ10 Ϫ4 M 3-isobutyl-1-methylxanthine) or with 1% of unfractionated SMP. Forskolin (50 M), a nonspecific stimulator of the adenylate cyclase, was used as positive control. Supernatants were analyzed in duplicate for their content of cAMP in a competitive RIA (Amersham Pharmacia Biotech). In brief, duplicates of cAMP standard and samples were diluted in assay buffer (0.05 M acetate buffer, 0.01% sodium azide) to a final volume of 500 l. Acetylation was performed by the addition of 25 l acetylation reagent (1 vol acetic anhydride and 2 vol triethylamine). Two aliquots (100 l) were transferred into the assay vials and incubated with 100 l [ 125 I] cAMP tracer and 100 l of antiserum (rabbit anti-succinyl cAMP serum) at 4°C for 15-20 h. For bound/free separation, 100 l donkey antirabbit IgG coated to magnetizable polymer particles was added, incubated for 10 min, then centrifuged and counted in a gamma counter (1470 Wizard, Wallac, Sweden) for 1 min. cAMP concentration of the samples were calculated after logit/log transformation of the cAMP standard curve.
Tyrosine phosphorylation
BPH-1 cells (5ϫ10 6 ) were starved in serum-free RPMI 1640 for 24 h. Medium was changed to RPMI 1640 containing 1% SMP or HPLC fraction '50 min' responsible for apoptosis. After 5 or 10 min, plates were placed on ice and washed with ice-cold PBS. Prechilled lysis buffer containing 20 mM HEPES pH 7.4, 2 mM EGTA, 50 mM ␤-glycerophosphate, 1 mM DTT, 1 mM Na 3 VO 4 , 1% Triton X-100, 10% glycerol, 2 M leupeptin, 10 U/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride was added and cells were scraped carefully from the plate with a rubber policeman. Cells were lysed on ice for at least 20 min. After centrifugation (10,000 g, 20 min, 4°C), the clear supernatant was harvested. Cell extracts were subjected to electrophoresis (10% acrylamide gel) and Western blot analysis was performed using an mAb directed against phosphotyrosine (clone 4G10, Upstate Biotechnology). Instead of skim milk powder, 3% BSA fraction V (Sigma) was used for blocking and mAb incubations. To ensure equal protein loading and membrane transfer, blots were stripped and reprobed with an mAb directed against the oncoprotein receptor erbB2 (clone Ab-10, Neomarkers, Union City, Calif.), which is known to be expressed in prostatic epithelial cells.
Terminal deoxynucleotidyl transferase (TdT) -mediated dUTP nick-end labeling (TUNEL)
Log-phase growing BPH-1 cells (1ϫ10 6 ) were stained for apoptotic DNA fragmentation with the in situ cell death detection kit (TUNEL) according the manufacturer's instruc- 
2 ). Subsequently they were harvested, washed in PBS, fixed in 4% paraformaldehyde (30 min), and permeabilized in 0.1% Triton X-100/0.1% sodium citrate on ice (2 min). Thereafter, 1 ϫ 10 5 cells were resuspended in 50 l TUNEL reaction mix containing FITC-dUTP and TdT, and incubated for 60 min at 37°C in a humidified chamber. The reaction was stopped by the addition of 2 l 0.5 M EDTA; after extensive washing in PBS, cells were embedded and viewed on the confocal scanning system.
RESULTS
SMP induces cell death on proliferating prostate epithelial cells
Single SMP preparations (nϭ12) and a pool of all SMPs were tested for growth-stimulatory or -inhibitory effects on immortalized prostatic epithelial cells (BPH-1). Induction of cell death was observed when cells were stimulated to growth in a dose-dependent manner. Ten of 12 SMP samples revealed the same apoptotic effect as the common SMP pool, whereas 2 samples of SMP were responsible for only a slight inhibition of growth (SMP concentration: 1%). Compared to the common pool and 10 other SMP samples, these two probands showed an unusual protein profile in the HPLC analysis with absence or significant reduction of the 2-4 kDa protein peak (peak 50 min; data not shown). Concentrations of 1% SMP were sufficient to induce loss of cell viability in BPH-1 cells with highly proliferative activity (Fig. 1B) . Serum-starved BPH-1 cells displaying a low proliferative activity were resistant to SMP-induced cell death and did not show significant reduction in cell viability within 24 h of incubation (Fig. 1A) .
A low molecular weight (LMW) factor of SMP is responsible for cell death
Direct comparison of the unfractionated SMP with each fraction revealed an interesting observation. Only fraction 50, eluted at 50 min and corresponding to a calculated 2-4 kDa, had an effect on BPH-1 cell viability similar to that seen with unfractionated SMP (Fig.  2A) . Most cells died within 20 h of incubation, when doses of ϳ1% were applied. This effect was not only specific for immortalized BPH-1 cells, as the responsible fraction 50 induced cell death in androgen-independent and -dependent prostate carcinoma cell lines PC-3 and LNCaP as well as in primary cultures of human prostate epithelial cells (Fig. 4) . Boiling of SMP (10 min, 100°C) had no influence on the activity of fraction 50. Proliferation assays were performed with two important prostaglandins (PGE) present in human SMP. Neither PGE-1 nor PGE-2 influenced BPH-1 cell growth and viability at concentrations ranging from 10 Ϫ5 to 10 Ϫ8 M. Essentially the same was found for sex steroid hormones, such as dihydrotestosterone and ␤-estradiol, tested at concentrations ranging from 10 Ϫ6 to 10 Ϫ9 M (data not shown). Thus, the low molecular factor presumably belonged to neither steroid hormones nor prostaglandins.
Signal transduction pathway of LMW SMP
Signal transduction of fraction 50 min (2-4 kDa) was investigated in comparison to unfractionated SMP. Activity of the adenylyl cyclase, based on the production of cAMP, was measured after 3 h of incubation with medium containing whole SMP or the purified single fractions, respectively. As expected, unfractionated SMP was a potent stimulator of the adenylyl cyclase. Compared to fractions 54 and 55, containing prostaglandins in M concentrations, fraction 50 increased intracellular cAMP levels fivefold above constitutively produced cAMP (Fig. 3A) . Tyrosine phosphorylation of membrane receptors and intracellular signal transduction molecules were also investigated (Fig. 3B) . Compared to untreated cells, incubation with fraction 50 did not alter membrane or intracellular protein phosphorylation within 10 min. In contrast, unfractionated SMP induced a strong phosphorylation of proteins of 185 and 125 kDa. The responsible factor was a protein with a molecular mass greater than 20 kDa (data not shown).
Morphological changes of nucleus and cytoskeleton induced by SMP
Cell morphology changed rapidly when human prostate epithelial cells were exposed to 2% SMP. Compared to untreated control cells, shrinkage of cytoplasm could be observed within 6 h of incubation (Fig.  4) , when cells also started to detach. This effect has been observed in immortalized BPH-1 cells, prostate cancer cell lines (PC3 and LNCaP), and primary cultures of human prostate epithelial cells (Fig. 4) . It is noteworthy that loss of filamentous actin and subsequent destruction of the organized cytoskeleton occurred after 6 h in UV-irradiated as well as in SMPexposed prostate epithelial cells. Nuclear morphology of BPH-1 cells changed significantly after SMP treatment, as shown by DAPI staining of the nuclear DNA (Fig. 7A ). Compared to untreated cells, incubation with SMP resulted in an increased condensation of nuclei and in irregularities of nuclear shape and size. UVirradiated cells displayed a weaker condensation of their nuclei.
SMP-induced loss of membrane asymmetry
Loss of phospholipid asymmetry in the cell membrane was observed in SMP-treated cells. Externalization of phosphatidylserine from the inner to the outer site of the cell membrane was measured by binding of FITCconjugated annexin V. Dead cells with destroyed cell membrane could be discriminated by double staining with propidium iodide. After 4 to 6 h, BPH-1 cells stained single positive for annexin V (Fig. 5B , lower right quadrant), indicating processes of membrane destabilization. The same was observed in UV-irradiated cells (1 kJ/m 2 ), where accumulation of early apoptotic cells could be detected (Fig. 5A, lower right  quadrant) . SMP-treated cells did not accumulate in the early apoptotic status, but migrated continuously in the late apoptotic/necrotic status and became double positive (Fig. 5B, upper right quadrant) .
SMP-induced DNA fragmentation
Nuclear fragmentation of BPH-1 cells was determined after 24 and 48 h of incubation with SMP (1%) and after UV irradiation (1 kJ/m 2 ) by FACS analysis with propidium iodide or TUNEL. Compared to proliferating BPH-1 cells, SMP was responsible for a decrease of G2/M phase cell nuclei and condensation of G1 phase nuclei after 24 h of incubation (Fig. 6) . Furthermore, G2/M phase cells disappeared after 48 h, and cells in G1 phase showed a strong fragmentation of their DNA, as was observed with UV-irradiated BPH-1 cells (Fig. 6) . SMP-induced DNA fragmentation was verified by TUNEL staining (Fig. 7B) . Compared to untreated control cells, SMP treatment of BPH-1 cells for 48 h resulted in a TUNEL-positive staining of ϳ30 Ϯ 4%.
SMP did not increase caspase 3 activity
Caspase 3 activity was proved either by cleavage of the natural substrate PARP or by the synthetic colorimetric peptide Ac-DEVD-pNA. Only UV irradiation resulted in increased caspase 3 activity, as determined by PARP Western blots. The caspase 3-specific 89 kDa fragment of PARP was clearly visible as early as 9 h after irradiation (Fig. 8A) , which was not the case in SMP-treated BPH-1 cells. The same results were obtained by measurement of caspase 3 activity with the synthetic substrate in cytosolic extracts of BPH-1 cells. Caspase 3 rapidly became activated (2 h after UV irradiation) and reached maximum activity after 4 h (Fig. 8B) . SMP treatment resulted in a complete proteolytical breakdown of PARP within 21 h of incubation, independent of caspase 3 activity (Fig. 8A) .
SMP-induced loss of mitochondrial potential and decreased Bcl-2 protein levels
Mitochondrial disintegration and loss of inner membrane potential occurred rapidly after SMP treatment of BPH-1 cells, as determined by staining with the mitochondrial potential sensitive dye JC-1. Exposure to SMP primarily resulted in an activation of mitochondria and a high oxidative potential, as indicated by strong red staining (Fig. 9B) . As a secondary event, mitochondria lost their potential into the cytoplasm, as visualized by strong green staining of organelles and cytoplasm (Fig. 9C) , followed by a loss of staining due to mitochondrial disintegration processes (Fig. 9D) . These processes occurred within the first 6 h after SMP contact, before dramatic changes of cellular and nuclear morphology became visible. The proto-oncogene Bcl-2 protein levels declined after SMP exposure and completely disappeared after 9 h of incubation (Fig.  10B) . In parallel, a protein of ϳ 38 kDa, cross-reacting with the Bcl-2 mAb, increased after 6 and 9 h of SMP treatment whereas Bax levels remained nearly unaltered within 9 h of such incubation.
SMP induced proteolytical cleavage of p53 and increased expression of the prostate apoptosis response gene (Par-4)
SMP exposure had an influence on the protein levels of the proapoptotic gene product p53. Due to viral immortalization, BPH-1 cells permanently express p53, inactivated by the large T antigen of SV40. Cellular p53 decreased immediately after SMP exposure and was cleaved to a shorter fragment of ϳ 45 kDa after 9 h (Fig. 10A) . Moreover, SMP exposure led to an increase of Par-4 protein; compared to proliferating control Figure 6 . SMP-induced nuclear condensation and fragmentation. BPH-1 cells were exposed to either UV irradiation (1 kJ/m 2 ) or 1% SMP, and their nuclei were analyzed for DNA content after 24 and 48 h. Nuclear DNA was stained with propidium iodide and cells then counted according to their nuclear size (FL-2: red fluorescence. y axis: events). Untreated proliferating cells displayed two peaks, representing cells in G1 and G2/M phase. After 24 h, both SMP treatment and UV irradiation resulted in a decrease of G2/M phase cells; after 48 h, nuclear fragmentation was clearly visible. 2 ) (A) or exposed to 2% SMP (B) were double stained with propidium iodide (FL-2, red fluorescence), binding to nucleic acids and with FITC-conjugated annexin V (FL-1, green fluorescence), binding to externalized phosphatidylserine. After 2, 4, and 6 h of incubation (37°C), they were analyzed in the FACS and compared to untreated proliferating control cells (control). Single-positive staining for annexin V, characteristic for externalization without loss of membrane integrity (i.e., early apoptotic cells), was observed in UV-irradiated (A) and SMP-exposed BPH-1 cells (B) as early as 4 h. Moreover, double-positive stained, late apoptotic cells could be observed 6 h after SMP exposure.
cells, Par-4 protein expression was up-regulated after 6 h and vanished after 9 h (Fig. 10C) .
DISCUSSION
Increasing human longevity has resulted in a commensurate increase in proliferative disorders of the prostate, a problem that also has an important economic impact. Treatment of PCa and BPH requiring surgical intervention costs more than $4 billion a year in the U.S. (14) . Thus, apart from better pathological understanding, preventative steps based on pharmacological therapeutics are necessary increasingly. Aside from hormonal changes in the elderly men, it has been assumed that BPH is caused by disturbances in apoptosis of stromal cells of the prostate (15) , which decreases with age, although the proliferative index remains unaltered (16) . Furthermore, degenerated prostatic epithelial cells, which evade apoptosis, accumulate mutations, become insensitive to further anti-growth signals, and acquire limitless replicative potential, forming the basis for neoplastic transformation and subsequent development of prostatic cancer (17) .
Growth of the prostate with age is a complex, poorly understood process. In addition to the indispensable steroid, testosterone, changes of endocrine factors, such as luteinizing hormone-releasing hormone, growth hormone, IGF-I, and PRL, have been shown to influence prostate growth homeostasis (3, 5, 6, 18, 19) . Moreover, local changes in the balance of growthpromoting and -inhibiting factors seem to be important mediators for the development of BPH (7) .
Prostate epithelial cells produce substances beneficial for optimal fertility, which might act in a retrograde manner on the epithelium by influencing cell proliferation, differentiation, and epithelial-stromal interactions. In this study, we describe the isolation of a potent apoptosis-inducing factor from human seminal fluid by HPLC. This molecule, presumably a small polypeptide with a molecular mass of ϳ3.5 kDa, superimposed all proliferative effects of other growth-promoting factors present in human SMP. Thus, unfractionated SMP did not enhance BPH-1 cell proliferation, but cells lost viability within 24 h under serum stimulation (Fig. 1B) . 'Programmed cell death' was determined by nuclear DNA fragmentation (Fig. 6 ) and early loss of phospholipid membrane asymmetry (Fig. 5) . Apoptosis could be induced with the SMP samples of 10 of 12 probands. Thus, the responsible substance must be present in the SMP of most males. Compared to the apoptosis-inducing SMP samples and the common SMP pool, these two patients had an unusual protein pattern and significant lower amounts of fraction 50 as determined by HPLC analysis (data not shown). Serum-starved BPH-1 cells displaying a very low proliferative activity responded to increasing concentrations of SMP with no significant loss of cell viability (Fig. 1A) , excluding the possibility that the substance might belong to bacterial endotoxins.
Signal transduction of fraction 50 was mediated primarily by activation of seven-transmembrane receptor molecules, stimulation of the adenylyl cyclase, and production of cAMP (Fig. 3A) . Many short peptides-up to 50 amino acid residues present in prostate and SMP, i.e., thyrotropin-releasing hormone-related polypeptides (20) -are known to exert their actions via stimulation of adenylyl cyclases. Presumably this cAMPmediated signal pathway led to apoptosis, since no predominant tyrosine phosphorylation of membrane receptors or associated protein kinases could be observed within 10 min after stimulation (Fig. 3B) . The involvement of cAMP in apoptosis is not very surprising, as cAMP-dependent protein kinases have been shown to regulate apoptosis by phosphorylation of Bcl-2 and reducing Bcl-2/Bax dimerization (21) . Elucidation of the SMP-triggered apoptotic mechanism revealed common processes, but also differences to the classic apo- ptotic stimulus, UV irradiation. Nuclear fragmentation (Fig. 6 ) and generation of DNA breaks (Fig. 7B) were quite similar in UV-irradiated and SMP-treated BPH-1 cells, and early apoptotic translocation of phosphatidylserine in the cell membrane (Fig. 5) and disintegration of filamentous actin cytoskeleton occurred within 6 h. In both apoptotic processes, TUNEL-positive cells, characteristic of late apoptosis and of increased DNA strand breaks and fragmentation were observed (Fig.  7B) . Most noteworthy, activation of caspase 3 and cleavage of PARP, a nuclear DNA repair protein characteristic of UV irradiation-induced apoptosis, was not detected in cells exposed to SMP (Fig. 8A, B) . Thus, the observed proteolytic breakdown of PARP between 18 and 21 h must be due to other caspases or proteases. SMP induced disintegration of mitochondria and activated mitochondrial-triggered apoptotic processes. A rapid loss of mitochondrial potential could be determined by the mitochondrial potential sensitive dye-JC-1 (Fig. 9A-D) . Further, a decline in mitochondrial Bcl-2 protein levels was observed that disappeared completely after 9 h of incubation, whereas Bax protein levels remained unaltered (Fig. 10B) . Thus, changes in the Bax/Bcl-2 ratio and in the mitochondrial rheostat of cell death and survival could be responsible for induction of apoptosis, as demonstrated with rodent prostate epithelial cells after castration (22) . Decreases of Bcl-2 protein levels have been shown to favor the formation of Bax/Bax homodimers, which in turn interact with the adenine nucleotide translocator and activate the mitochondrial permeability transition pore complex (23) . Recently, it has been demonstrated that overexpression of Bax-like proteins or their enforced dimerization kills mammalian cells by provoking DNA condensation and membrane alterations without involvement of caspase activation (24) . This observation could explain why SMP treatment induced apoptosis without the involvement of the key caspase, caspase 3. Presumably, alterations in the relative concentrations of mitochondrial Bcl-2 pro-and antiapoptotic family members were sufficient to induce apoptosis.
SMP treatment resulted in an immediate increase of cellular p53 protein levels after 3 h of incubation, which might be a consequence of increased protein Figure 8 . BPH-1 caspase 3 activity after exposure to SMP or UV irradiation. A) Cleavage of the native substrate of caspase 3, the nuclear enzyme PARP involved in DNA repair, was determined after exposure to 1% SMP or after UV irradiation. Apart from the full-length 116 kDa PARP, protein proliferating BPH-1 cells (co.) expressed an ϳ 50 kDa PARP molecule, presumably a degradation product. UV irradiation resulted in activation of caspase 3 and the cleavage of 116 kDa PARP in a shorter fragment of 89 kDa. This fragment was specific for UV treatment and could not be observed in SMP-treated cells. PARP of SMP-treated cells was proteolytically degraded between 18 and 21 h of incubation, independent of caspase 3 activity. B) Caspase activity was further determined by a caspase 3-specific assay, based on the cleavage of the colorimetric substrate Ac-DEVD-pNA. As expected, only UV irradiation (1 kJ/m 2 ) activated caspase 3; SMPtreated BPH-1 cells did not alter their caspase 3 activity. stability or reduced ubiquitinylation and degradation. In the initial stages of apoptosis, high p53 levels might be important to prevent further cell divisions, provoke growth arrest, and ensure DNA repair. In later stages of apoptosis, p53 was cleaved (Fig. 10A) ; at this point, inhibition of DNA repair by cleavage of p53 might be necessary to ensure the completion of apoptosis. Proteolytic cleavage of p53 has been reported to be important for the activation of this molecule in response to DNA damage and for interaction with single-stranded DNA (25) . Since BPH-1 cells are SV 40 large T immortalized, SMP-induced changes in p53 protein were also analyzed in nonimmortalized primary cultures of human prostate epithelial cells. Again, after an initial increase, p53 protein degradation occurred within 6 -9 h (data not shown). Apart from p53, prostate apoptosis response 4 gene (Par-4) protein levels were elevated in early SMP-induced apoptosis. Par-4, a leucin zipper protein with nuclear localization sequence, has been discovered to be a differentially regulated gene in androgen-dependent apoptosis of rodent prostate epithelial cells (26) . Moreover, Par-4 has been shown to be up-regulated in an apoptosis-specific manner and not to be induced by effectors of growth stimulation, oxidative stress, growth arrest, or necrosis (27) . Most significant, protein levels of Par-4 could only be detected after 6 h in the cytoplasm of SMP-treated cells, whereas it vanished again after 9 h, possibly due to apoptosis-specific gene expression in the first stages of apoptosis followed by rapid degradation (Fig. 10C) .
Better characterization of the apoptosis-inducing 2-4 kDa fraction of human SMP remains to be achieved. This fraction contains a potent inducer of apoptosis acting primarily on proliferating cells, as shown for nonimmortalized and immortalized human prostate epithelial cells and for prostatic cancer cell lines PC-3 and LNCaP. This molecule could be physiologically important either for the elimination of old degenerated secretory epithelial cells or for differentiation processes occurring in the permanent renewal of prostatic epithelium. Additional studies will provide insight as to how this factor influences renewal and secretory function of the prostate epithelium, and elucidate whether changes in its concentration contribute to the development of BPH or prostatic cancer. Figure 10 . SMP altered levels of pro-and antiapoptotic proteins. A) Cellular p53 protein levels of BPH-1 cells were analyzed 3, 6, and 9 h after exposure to 2% SMP. An increase in p53 protein stability could be observed 3 to 6 h after stimulation with SMP, and after 9 h proteolytic degradation of p53 occurred. In contrast, cellular protein levels of PCNA involved in DNA replication and repair remained unaltered. B) Cellular Bcl-2 protein levels decreased in BPH-1 cells after exposure to SMP. In contrast to the relatively unaltered cellular bax levels, SMP decreased Bcl-2 protein levels within 9 h. Simultaneous with the Bcl2 degradation, an increase of a Bcl-2-related protein of ϳ 38 kDa could be observed. C) Par-4 protein levels dramatically increased ϳ 6 h after exposure to SMP, but disappeared rapidly, presumably due to proteolytic breakdown. The same blot was stripped and reprobed with cytochrome c immunoglobulins. Total cytochrome c protein levels, consisting of mitochondria bound and protein released in the cytoplasm, remained constant and served as control for equal loading and membrane transfer.
